Europe Airway Management Devices Market

The airway management devices market in Europe is expected to grow from US$ 508.81 million in 2022 to US$ 762.14 million by 2028. It is estimated to grow at a CAGR of 7.0% from 2022 to 2028.

Rising Prevalence of Respiratory Disorders

Chronic respiratory diseases are among the most prevalent noncommunicable diseases worldwide due to the increase in the noxious environment and occupational and behavioral inhalation. This spectrum of diseases includes chronic obstructive pulmonary disease (COPD), asthma, interstitial lung disease, pulmonary sarcoidosis, and pneumoconiosis (such as silicosis and asbestosis). According to the World Health Organization (WHO), COPD is the third leading cause of death. The National Health Service states that ~1.17 million people in the UK were diagnosed with COPD in 2021, i.e., ~1.9% of the total population. The rising prevalence of respiratory disorders is driving the demand for airway management devices. Additionally, there is a constant surge in the number of hospitals, ambulatory surgical centers, intensive care units, and clinics, creating the demand for airway management devices. Various organizations and government bodies are collaborating to increase awareness among a large population and manage chronic disorders. Government authorities and healthcare institutions are implementing various programs to increase asthma awareness to prevent morbidity from the disease. The program is dedicated to conducting asthma surveillance and research to deal with the disease. Additionally, Airway Collaborative is an education program designed to provide medical professionals with knowledge about incorporating airway treatment into practice and healing airway dysfunctions. Thus, the factors mentioned above are driving the airway management devices market.

Market Overview

The European airway management devices market is divided into Germany, France, the UK, Italy, Spain, and the Rest of Europe. Countries such as Germany and France are expected to be the most significant contributors to the airway management devices market due to rising COPD cases. In comparison, countries such as the UK and Italy are estimated to be the fastest-growing countries in the market as the countries offer the best healthcare facilities in the region. On the other hand, Italy is expected to have growth opportunities for the market, owing to the rising healthcare expenditure.

 Europe Airway Management Devices Market Revenue and Forecast to 2028 (US$ Million)

Europe Airway Management Devices Market Segmentation

The Europe airway management devices market is segmented into product and end user.

• Based on product, the market is segmented into infraglottic devices, supraglottic devices, laryngoscopes, resuscitators, and others. The infraglottic devices segment registered the largest market share in 2022.
• Based on end user, the market is categorized into hospitals, ambulatory surgical care centers, and others. The hospitals segment held the largest market share in 2022. 
• Based on country, the market is segmented into Germany, France, the UK, Italy, Spain, and the Rest of Europe. The Rest of Europe dnated the market in 2022.

Teleflex Incorporated; Smiths Medical; Medtronic; Intersurgical Ltd; Ambu A/S; Medline Industries, Inc.; Koninklijke Philips N.V.; ARMSTRONG MEDICAL; and Cook Medical LLC are among the leading companies operating in the airway management devices market in the region.  

Europe Airway Management Devices Market Strategic Insights

Europe Airway Management Devices Market Segmentation Analysis

Europe Airway Management Devices Market Report Highlights

Europe Airway Management Devices Report Scope

Europe Airway Management Devices Market Country and Regional Insights